Dubai, UAE: Nabta Health, the Middle East’s only hybrid healthcare platform dedicated to elective, preventive women’s healthcare, has raised $1.5 million in a new angel investment round.
The funding round is led by Basim Anwer of Regionality Group of Companies, with participation from notable angel investors including Priya Oberoi, Founding General Partner of Goddess Gaia Ventures, Dr. Sarper Tanli, Operating Partner of TVM Capital Healthcare, and Nadia Mannell, Founding General Partner of Seed South Capital.
The femtech firm’s Seed financing will be used to expand Nabta Health’s product portfolio to include a number of B2B SaaS offerings, and to expand its market share within the UAE. Over the last 12 months, Nabta Health has launched the woman-centric, goal-oriented Nabta App with Aya, established an ecosystem of health and wellness providers through a B2C marketplace, signed exclusive distribution agreements for MENA with several high profile femtech companies including viO HealthTech (previously: Fertility Focus), and established partnerships with some of the leading value- and risk-based healthcare providers in the region.
Sophie Smith, CEO and Founder of Nabta Health, said:
“We are super proud to have closed our Seed funding round. We are optimistic about Nabta Heath’s growth potential in the UAE in the near-term and will be focusing our energy on our business-to-business offering, which is due to launch officially in the first-half of the year; as well as elevating further our product offering on our consumer-dedicated platform.
“The femtech market is still very, very nascent in the emerging markets. Fewer than 1% of femtech companies target countries such as the UAE and Saudi, despite there being a sizeable, largely untapped market opportunity and a real human need. Nabta Health is in a unique position now to be the leader in femtech health and wearables in the GCC, and we are excited with what the future holds for us.”
Basim Anwer, Founder, Regionality Group of Companies, said:
“The global femtech market is a $22 billion market projected to grow exponentially in the next 5 years. With millions of women in the region and large gaps in affordable healthcare for women, the real question was with whom and when to invest in femtech. This question was answered with the foresight of Sophie Smith and the hybrid healthcare model of Nabta Health.”
Priya Oberoi, Founding General Partner, Goddess Gaia Ventures, said:
"I invested in Nabta Health because I believe we are doing something with a higher purpose, to meet the needs of an essential and underserved market. I love Sophie’s gumption and tenacity, and it is what will drive Nabta Health forwards during this next phase of growth.”
A selection of Nabta Health’s existing angel investors from its Pre-Seed round also participated in the Seed round.
© Press Release 2022
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
